Disrupting the Borg is expensive and time consuming!
Google Search
-
Recent Posts
- First Female President
- “not supported by the scientific consensus”
- Cooling Is Warming
- Still Spamming And Scamming
- The End Of Snow
- 117 MPH Winds In Ireland
- The End Of “Climate Action”
- Data Made Simple – Weather History Part II
- New Arctic Climate Discovered
- Airport Runways Cause Bad Weather
- Flooding Of January 1862
- Moving To Detroit To Escape Global Warming
- Visitech.ai – Data Made Simple – Weather History
- First Tracks In The Snow
- UK Green Energy Record
- UN Is Upset
- “Fascist Salute”
- Record Warmth Of January 1906
- Heat Trapping Difficulties
- Visitech – Data Made Simple – Antarctic Sea Ice
- Visitech – Data Made Simple
- California Governor Refused Firefighting Help
- Internet For Drowned Island
- A Toast To President Trump
- 97% Of Government Experts Agree
Recent Comments
- arn on First Female President
- Russell Cook on First Female President
- Margaret Smith on “not supported by the scientific consensus”
- arn on First Female President
- Trevor on First Female President
- Richard E Fritz on Cooling Is Warming
- Richard E Fritz on First Female President
- dm on “not supported by the scientific consensus”
- Gordon Vigurs on “not supported by the scientific consensus”
- Jack the Insider on “not supported by the scientific consensus”
President Obama Unveils The Secret Ingredient Behind His Plan To End Billions Of Years Of Bad Weather
This entry was posted in Uncategorized. Bookmark the permalink.
Someone bled him?
Do leeches bleed?
Reblogged this on CraigM350.
I can’t hear a thing!
Drug reps try to sell physicians the same crap.
E.g. atypical antipsychotics control mood disorders, but drug reps minimize the idiosyncratic reactions, as well as the common result that patients get fat and diabetic on these meds.
Lesson: always be a science skeptic, especially where money is involved.
I’m not saying that these drugs suck, just that there is always pro and con, or a case for and against, risks and benefits, opportunity cost, trade-offs, etc.